USPH
NYSE · Health Care
U.S. Physical Therapy Inc
$74.40
-0.56 (-0.75%)
Financial Highlights (FY 2026)
Revenue
676.59M
Net Income
31.67M
Gross Margin
19.1%
Profit Margin
4.7%
Rev Growth
+10.7%
D/E Ratio
0.31
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 19.1% | 19.1% | 53.4% | 53.4% |
| Operating Margin | 9.4% | 8.5% | 12.3% | 13.8% |
| Profit Margin | 4.7% | 4.5% | 12.4% | 11.7% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 676.59M | 611.25M | 680.46M | 584.51M |
| Gross Profit | 129.30M | 116.81M | 363.55M | 312.28M |
| Operating Income | 63.73M | 51.82M | 83.61M | 80.89M |
| Net Income | 31.67M | 25.75M | 84.11M | 68.29M |
| Gross Margin | 19.1% | 19.1% | 53.4% | 53.4% |
| Operating Margin | 9.4% | 8.5% | 12.3% | 13.8% |
| Profit Margin | 4.7% | 4.5% | 12.4% | 11.7% |
| Rev Growth | +10.7% | +10.7% | +22.6% | +15.8% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 146.46M | 146.46M | 109.70M | 120.61M |
| Total Equity | 466.43M | 466.43M | 934.36M | 966.56M |
| D/E Ratio | 0.31 | 0.31 | 0.12 | 0.12 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | 82.23M | 70.57M | 108.87M | 97.49M |
| Free Cash Flow | — | — | 45.81M | 45.13M |